0
ARTICLE |

Adenosine 3',5'-Monophosphate and Mania FREE

Herbert Meltzer, MD
JAMA. 1971;216(11):1856-1857. doi:10.1001/jama.1971.03180370130026
Text Size: A A A
Published online

Adenosine 3',5'-monophosphate (cyclic AMP) is currently of intense interest to scientists in many fields of biology and medicine. Cyclic AMP plays a central role in the mediation of hormonal actions and the regulation of metabolic processes.1 There is considerable experimental evidence for an important role of cyclic AMP in brain function.2 Intracellular cyclic AMP levels may be increased or decreased by a variety of hormones and neurotransmitters, probably through stimulation or inhibition of the activity of adenyl cyclase, the enzyme which synthesizes cyclic AMP.1,2 The mode of action of theophylline and aminophylline in the treatment of heart failure and bronchial asthma has been attributed to the inhibition of phosphodiesterase (the enzyme which catabolizes cyclic AMP), producing increased intracellular cyclic AMP levels in the myocardium and bronchial muscle, which results in more vigorous myocardial contraction and in bronchial dilatation.3

Studies of hormonal and neutrotransmitter excesses, deficiencies, and

REFERENCES

Sutherland EW, Robinson GA, Butcher RW:  Some aspects of the biological role of adenosine 3',5'-monophosphate (cyclic AMP) . Circulation 37:279-306, 1968;.
Rall TW, Kakiucki S:  The influence of certain neurohumors and drugs on the accumulation of 3',5'-AMP in brain tissue , in Carlson P (ed): Molecular Basis of Some Aspects of Mental Activity . London, Academic Press, 1966;, vol 1, pp 417-427.
Breckenridge BM:  Cyclic adenosine monophosphate and drug action . Ann Rev Pharmacol 10:19-34, 1970;.
Paul MI, Ditzion B, Janowsky D:  Affective illness and cyclic-AMP excretion . Lancet 1:88, 1970;.
Paul MI, Cramer H, Goodwin FK:  Urinary cyclic AMP in affective illness . Lancet 1:996, 1970;.
Paul MI, Ditzion BR, Pauk GL, et al:  Urinary adenosine 3',5'-monophosphate excretion in affective disorders . Amer J Psychiat 126: 1493-1497, 1970;.
Abdulla YH, Hamadah K:  3',5' Cyclic adenosine monophosphate in depression and mania . Lancet 1:378-381, 1970;.
Robinson GA, Coppen AJ, Whybrow PC, et al:  Cyclic AMP in affective disorders . Lancet 2:1028-1029, 1970;.
Paul MI, Cramer H, Bunney WE:  Urinary adenosine 3',5'-monophosphate in the switch process from depression to mania . Science 171:300-303, 1971;.
Schildkraut JJ:  The catecholamine hypothesis of affective disorders: A review of supporting evidence . Amer J Psychiat 122:509-522, 1965;.
Bunney WE, Murphy DL, Goodwin FK:  The switch process from depression to mania: Relationship to drugs which alter brain amines . Lancet 1:1022-1027, 1970;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Sutherland EW, Robinson GA, Butcher RW:  Some aspects of the biological role of adenosine 3',5'-monophosphate (cyclic AMP) . Circulation 37:279-306, 1968;.
Rall TW, Kakiucki S:  The influence of certain neurohumors and drugs on the accumulation of 3',5'-AMP in brain tissue , in Carlson P (ed): Molecular Basis of Some Aspects of Mental Activity . London, Academic Press, 1966;, vol 1, pp 417-427.
Breckenridge BM:  Cyclic adenosine monophosphate and drug action . Ann Rev Pharmacol 10:19-34, 1970;.
Paul MI, Ditzion B, Janowsky D:  Affective illness and cyclic-AMP excretion . Lancet 1:88, 1970;.
Paul MI, Cramer H, Goodwin FK:  Urinary cyclic AMP in affective illness . Lancet 1:996, 1970;.
Paul MI, Ditzion BR, Pauk GL, et al:  Urinary adenosine 3',5'-monophosphate excretion in affective disorders . Amer J Psychiat 126: 1493-1497, 1970;.
Abdulla YH, Hamadah K:  3',5' Cyclic adenosine monophosphate in depression and mania . Lancet 1:378-381, 1970;.
Robinson GA, Coppen AJ, Whybrow PC, et al:  Cyclic AMP in affective disorders . Lancet 2:1028-1029, 1970;.
Paul MI, Cramer H, Bunney WE:  Urinary adenosine 3',5'-monophosphate in the switch process from depression to mania . Science 171:300-303, 1971;.
Schildkraut JJ:  The catecholamine hypothesis of affective disorders: A review of supporting evidence . Amer J Psychiat 122:509-522, 1965;.
Bunney WE, Murphy DL, Goodwin FK:  The switch process from depression to mania: Relationship to drugs which alter brain amines . Lancet 1:1022-1027, 1970;.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.